Remove 2024 Remove Arrhythmia Remove Circulation
article thumbnail

Ablation of Cardiac Arrhythmias: Past, Present, and Future

Circulation

Circulation, Volume 150, Issue 1 , Page 4-6, July 2, 2024.

article thumbnail

Abstract 4138334: Identification and Immunological Characterization of Arrhythmia-Related Molecular Clusters in Ischemic Cardiomyopathy

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4138334-A4138334, November 12, 2024. Ischemic cardiomyopathy, a severe cardiac condition resulting from prolonged myocardial ischemia, is characterized by ventricular dilation, dysfunction, and an increased risk of life-threatening arrhythmias.

article thumbnail

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable?

Circulation

Circulation, Volume 150, Issue 21 , Page 1669-1670, November 19, 2024.

article thumbnail

Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias

Circulation

Circulation, Volume 149, Issue 6 , Page 475-480, February 6, 2024.

article thumbnail

Abstract Su505: Impact of a Targeted Automated External Defibrillator (AED) Program on Survival After Ventricular Fibrillation Cardiac Arrest in the Sao Paulo Metropolitan Subway System: A Landmark Initiative in Latin America

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page ASu505-ASu505, November 12, 2024. The targeted Automated External Defibrillator (AED) program in the Sao Paulo Metro has yielded promising results in improving survival rates for individuals experiencing out-of-hospital cardiac arrest (OHCA) due to ventricular arrhythmias.

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Circulation. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.

article thumbnail

Correction to: Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association

Circulation

Circulation, Volume 149, Issue 12 , Page e996-e996, March 19, 2024.